Results 161 to 170 of about 44,651 (208)

Interferon alfa-2a.

British journal of hospital medicine, 1997
Interferon alfa-2a shows both antiviral and antitumoral activity, but its role in the treatment of many conditions remains controversial. It is, however, the treatment of choice for chronic, active hepatitis B, chronic hepatitis C and AIDS-related Kaposi's sarcoma, and is also effective in metastatic renal carcinoma and chronic myelogenous leukaemia ...
C D, Williams, D C, Linch
openaire   +1 more source

Interferon-alfa for chronic myeloid leukemia

Seminars in Hematology, 2003
Interferon-alfa (IFNalpha) became the first-line agent for the treatment of chronic myeloid leukemia (CML) because it prolongs survival significantly compared to conventional chemotherapy (CHT). Responses to IFNalpha and the benefits from achieving a response are greater in low-risk than in high-risk patients.
Baccarani, Michele, Russo, Domenico, Rosti, Gianantonio, Martinelli, Giovanni   +3 more
openaire   +3 more sources

Myasthenia gravis during interferon alfa therapy

Neurology, 1995
Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies.
Batocchi, Anna Paola, Evoli, Amelia, Servidei, Serenella, Palmisani, Mt, Apollo, F, Tonali, Pietro Attilio   +5 more
openaire   +3 more sources

Combination therapy with interferon alfa and ribavirin in interferon alfa relapsers

1996
Not ...
Ricchiuti A, Ciccorossi P, Costa F, Bellini M, Tumino E, Petruccelli S, Maggi F, Vatteroni L, PISTELLO, MAURO, Bendinelli M, Maltinti G, Marchi S.   +11 more
openaire   +2 more sources

Interferon ALFA

Neurology, 1996
Ken Ikeda, Masao Kinoshitz
openaire   +1 more source

Interferon Alfa-2b

2022
Michelle C. Simpson, Eric G. Schaefer
openaire   +1 more source

INTERFERON ALFA

Reactions Weekly, 2015
openaire   +2 more sources

Interferon alfa, peginterferon alfa and retinopathy.

Prescrire international, 2006
(1) Retinal damage is a known adverse effect of interferon alfa. (2) Similar adverse effects have been reported with pegylated interferon alfa. The disorders generally regress within a few months, despite continued treatment.
openaire   +1 more source

Interferon alfa

Reactions Weekly, 1994
openaire   +1 more source

Interferon Alfa

2010
Jason Grebely, Greg Dore
openaire   +1 more source